DeepMed Research

NATIONAL UNIVERSITY HOSPITAL (SINGAPORE) PTE LTD

🇸🇬Singapore

Country: 🇸🇬Singapore

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Weight Loss for a Healthier You Programme

Not Applicable

Conditions: Ketogenic Dieting
Weight Loss
Obesity
Metabolic Syndrome

Interventions: Other: Calorie-Restricted Low Fat Diet
Other: Calorie-Restricted Healthy Ketogenic Diet

First Posted Date: 2021-09-20

Last Posted Date: 2022-09-23

Lead Sponsor: National University Hospital, Singapore

Target Recruit Count: 70

Registration Number: NCT05049954

Locations: 🇸🇬
National University Hospital, Singapore, Singapore

CARTALL: Chimeric-Antigen Receptor (CAR) T-Cell Therapy for Relapsed/ Refractory T-Lineage Acute Lymphoblastic Leukaemia

Phase 1

Recruiting

Conditions: Lymphoblastic Leukemia, Acute Adult
Refractory Leukemia
Lymphoblastic Leukemia, Acute, Childhood
CAR
CAR T-Cell-Related Encephalopathy Syndrome
Lymphoblastic Leukemia
Lymphoblastic Leukemia in Children

Interventions: Biological: CAR T-cell therapy

First Posted Date: 2021-09-14

Last Posted Date: 2021-09-14

Lead Sponsor: National University Hospital, Singapore

Target Recruit Count: 20

Registration Number: NCT05043571

Locations: 🇸🇬
Allen Yeoh Eng Juh, Singapore, Singapore

ALaCART-B: Acute Leukemia and Chimeric Antigen Receptor-T Cell Therapy for B-lymphoblastic Leukemia.

Phase 1

Recruiting

Conditions: CAR T-Cell-Related Encephalopathy Syndrome
Lymphoblastic Leukemia, Acute, Childhood
Lymphoblastic Leukemia, Acute Adult
Lymphoblastic Leukemia in Children
CAR
Lymphoblastic Leukemia

Interventions: Biological: CAR T-cell therapy

First Posted Date: 2021-09-09

Last Posted Date: 2021-09-09

Lead Sponsor: National University Hospital, Singapore

Target Recruit Count: 40

Registration Number: NCT05038696

Locations: 🇸🇬
Allen Yeoh Eng Juh, Singapore, Singapore

Osimertinib for Advanced EGFR-positive NSCLC Patients

Recruiting

Conditions: Non Small Cell Lung Cancer
EGFR Positive Non-small Cell Lung Cancer

First Posted Date: 2021-09-08

Last Posted Date: 2021-09-08

Lead Sponsor: National University Hospital, Singapore

Target Recruit Count: 58

Registration Number: NCT05037331

Locations: 🇸🇬
National University Hospital, Singapore, Singapore

Selinexor & Talazoparib in Advanced Refractory Solid Tumors; Advanced/Metastatic Triple Negative Breast Cancer (START)

Phase 1

Recruiting

Conditions: Advanced Triple Negative Breast Cancers
Advanced Refractory Solid Tumors
Metastatic Triple Negative Breast Cancers

Interventions: Drug: Talazoparib
Drug: Selinexor

First Posted Date: 2021-09-05

Last Posted Date: 2024-05-17

Lead Sponsor: National University Hospital, Singapore

Target Recruit Count: 63

Registration Number: NCT05035745

Locations: 🇸🇬
National University Hospital, Singapore, Singapore

The Southeast and East Asian Post-Operative Delirium (SEAPOD) Study

Recruiting

Conditions: Postoperative Delirium
Hip Fractures

Interventions: Other: Neurocognitive tests

First Posted Date: 2021-08-11

Last Posted Date: 2022-10-06

Lead Sponsor: National University Hospital, Singapore

Target Recruit Count: 1000

Registration Number: NCT04999891

Locations: 🇰🇷
St Mary's Hospital, Seoul, Korea, Republic of
🇰🇷
Severance Hospital, Seoul, Korea, Republic of
🇸🇬
National University Health System, Singapore, Singapore

and more 10 locations

Observational Study of Afatinib 30 mg Daily

Recruiting

Conditions: Non-Small Cell Lung Cancer
Epidermal Growth Factor Receptor Mutation

Interventions: Drug: Afatinib

First Posted Date: 2021-06-01

Last Posted Date: 2024-05-17

Lead Sponsor: National University Hospital, Singapore

Target Recruit Count: 69

Registration Number: NCT04909073

Locations: 🇸🇬
Nationa University Hospital, Singapore, Singapore

El DORADO STUDY (Evaluation of Delivery of Oxygen on Renal, Arrhythmia and Delirium Outcomes Study)

Recruiting

Conditions: Atrial Fibrillation
AKI
Neurocognitive Disorders

Interventions: Device: Edwards ClearSight and Masimo SET

First Posted Date: 2021-05-20

Last Posted Date: 2023-07-27

Lead Sponsor: National University Hospital, Singapore

Target Recruit Count: 600

Registration Number: NCT04895384

Locations: 🇸🇬
National University Hospital, Singapore, Singapore
🇸🇬
Singapore General Hospital, Singapore, Singapore

A Phase I Dose Escalation Study of Selinexor Plus Nivolumab and Ipilimumab in Advanced/Metastatic Solid Malignancies

Phase 1

Recruiting

Conditions: Advance Solid Malignancies
Metastatic Solid Malignancies

Interventions: Drug: Selinexor in combination with nivolumab and ipilimumab

First Posted Date: 2021-04-20

Last Posted Date: 2021-04-20

Lead Sponsor: National University Hospital, Singapore

Target Recruit Count: 30

Registration Number: NCT04850755

Locations: 🇸🇬
National University Hospital, Singapore, Singapore, Singapore

CURATE.AI COR-Tx Trial for Post Brain Radiotherapy Patients

Not Applicable

Conditions: Cognitive Decline

Interventions: Device: CURATE.AI

First Posted Date: 2021-04-19

Last Posted Date: 2021-11-12

Lead Sponsor: National University Hospital, Singapore

Target Recruit Count: 15

Registration Number: NCT04848935

Locations: 🇸🇬
National University Hospital, Singapore, Singapore
🇸🇬
The N.1 Institute for Health (N.1), NUS, Singapore, Singapore

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy